Mather Group, Llc. Moderna, Inc. Transaction History
Mather Group, Llc.
- $7.67 Billion
- Q4 2024
A detailed history of Mather Group, Llc. transactions in Moderna, Inc. stock. As of the latest transaction made, Mather Group, Llc. holds 678 shares of MRNA stock, worth $22,102. This represents 0.0% of its overall portfolio holdings.
Number of Shares
678
Previous 1,281
47.07%
Holding current value
$22,102
Previous $85,000
67.06%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding MRNA
# of Institutions
909Shares Held
235MCall Options Held
10.6MPut Options Held
18.6M-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.31 Billion0.05% of portfolio
-
Baillie Gifford & CO38.9MShares$1.27 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$833 Million0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$549 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$236 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $12.8B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...